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Journal of Health Monitoring. It will be followed up by a 
series of further issues that set out the results.
The articles in the current issue on the ‘cross-sectional’ 
and ‘longitudinal’ components of KiGGS (KiGGS Wave 2 
cross-sectional study – participant acquisition, response 
rates and representativeness, KiGGS Wave 2 longitudinal 
component – data collection design and developments in 
the numbers of participants in the KiGGS cohort) lay the 
foundations for understanding and classifying further 
results from KiGGS Wave 2. This is essential because 
KiGGS is a highly complex study consisting of two com-
ponents and two different concerns.
On the one hand, we want to present representative 
findings about the health and health-related behaviour of 
the next generation: how high is the proportion of over-
weight or obese children and adolescents? Has this per-
centage continued to increase over the last eleven years 
or has the increase been stopped? Do more or fewer teen-
agers smoke today? Which developments have taken place 
in relation to physical activity? In short: is the health of 
children and adolescents in Germany getting better or 
worse? And, have prevention measures already begun to 
show results? Our population-based cross-sectional data 
can be used to draw conclusions about trends such as 
these. As part of the health monitoring framework, KiGGS 
is focused on one of the most important fields of action 
in public health: monitoring the health and the health- 
Editorial: New information from and about the KiGGS study
This issue of the Journal of Health Monitoring focuses on 
one main topic: presenting the very first results from 
KiGGS Wave 2. After the first population-based health 
examination survey for children and adolescents (KiGGS 
baseline study) and its first follow-up survey (KiGGS 
Wave 1), many people are looking forward to the results 
of KiGGS Wave 2 – not just epidemiologists, but also 
(health) policy makers, paediatricians, representatives of 
the public health service, health insurers and also many 
parents. As the people responsible for planning and imple-
menting KiGGS Wave 2, we certainly feel the same way. 
The eagerness with which everyone is awaiting the results 
reflects the relevance of this study. Information about the 
effectiveness of interventions and preventive measures, 
about whether the goals and sub-goals defined in the 
national health target ‘Growing up healthy’ have been 
achieved, and about developments in health during the 
transition from adolescence to adulthood can help deliver 
a strong foundation for the future promotion of the health 
of children and adolescents living in Germany. We could 
have continued working on the preparation and quality 
assurance of our data for several more months before pre-
senting as many findings as possible as part of a single 
‘major’ project. Instead, we have decided to hold a public 
symposium under the motto ‘New information from and 
about the KiGGS study’ on March 15, 2018 and to publish 
the first findings from KiGGS Wave 2 in this issue of the 
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sample points used for the baseline study. There, exami-
nations were undertaken for the participants of the new 
cross-sectional sample as well as the children, adolescents 
and young adults from the KiGGS cohort. This decision 
came with a price: on the one hand, it made the work of 
the field teams, the study office and the home visits prior 
to the survey enormously complex, employing various 
instruments during the examinations and interviews 
required a lot of concentration and could not be allowed 
to have an impact on each of the other parts of the study. 
It was not possible to achieve this equally well in every 
case and at all locations. On the other hand, establishing 
examination centres in the 167 sites where the KiGGS base-
line study was conducted came with a disadvantage for 
the young adults belonging to the cohort, as they were 
often unable to participate in on-site examinations. Young 
adults are a highly mobile group and a large proportion 
of the cohort no longer lives in the locations where they 
were examined for the baseline study – the 167 places of 
residence at the beginning of the study have now trans-
formed into almost 2,000. As such, we could only write 
to the participants who had moved away, send them a 
questionnaire, and ask them to return it. Unfortunately, in 
many cases this meant that a central aspect of the study 
was missing – the examination. A lot of effort was put into 
encouraging the participants to fill out the questionnaire 
online within an extension period. Since the cohort is such 
a valuable component of KiGGS and remains unique in 
Germany, the follow-ups were only finished in August 2017. 
This is why for the KiGGS symposium and this issue of 
the Journal of Health Monitoring, analyses on topics from 
the interviews could only be performed using data from 
related behaviour of a vital section of the population – 
children and adolescents. Studies such as KiGGS always 
leave us better informed than we were before they were 
undertaken; for instance, changes in the educational and 
social structures always have an impact on health and they 
are reflected in our results.
The other – no less important – set of issues covered 
by the study are the developments in health that occur 
during the life course. If we are to understand when is the 
most favourable window to implement preventive mea-
sures and interventions or to set the course for health- 
related behaviour in years to come, we will need more 
than just a description of trends. What are the chances 
of an obese child having a normal weight during adult-
hood? At what age is smoking particularly dangerous, 
because after that, it becomes very difficult to quit? Is 
there a specific influencing factor, which, in the presence 
of allergic sensitisation, later leads to allergic diseases 
and the symptoms that they are associated with? These 
questions can be answered using data from the second 
component of KiGGS Wave 2 – the KiGGS cohort.
Data for ‘our’ KiGGS cohort is collected from the chil-
dren and adolescents who took part in the KiGGS baseline 
study between 2003 and 2006. During the baseline study, 
we asked the participants whether they would be willing 
to take part in the cohort – we received an overwhelmingly 
positive response. Nevertheless, it was and will continue 
to be difficult to integrate people who are now between 
10 and 31 years of age into our study. This problem was 
further complicated by the study design of KiGGS Wave 2: 
in order to improve field-work efficiency and minimise 
costs, the examinations were conducted in the same 167 
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the design of this part of the study (which brings to an end 
the  principle of undertaking examinations in examination 
centres) and employ different methods to those that have 
been used so far (will we succeed in decentralising meas-
urements, obtaining information using health apps and 
binding young adults to the study through cleverly chosen 
incentives?). As such, the questions employed in the study 
and the methods of analysis will change; in fact, this has 
already begun to take place. The first three waves of exam-
inations and interviews, which also contain information 
obtained through the parents, generated about 200 million 
data points. We are currently in the process of using a doc-
toral project to develop new methods of digital epidemiol-
ogy, machine learning and pattern recognition to identify 
correlations at the descriptive level. We then intend to model 
and test the results using classical epidemiological meth-
ods. Incidentally, our cohort dataset holds so much poten-
tial and is so complex and valuable that we will soon begin 
to undertake joint analyses through cooperation agreements 
as part of in-depth analysis projects.
In addition to information on health status and 
health-related behaviour, which we would very much like 
to continue collecting for life course research, we will also 
be adding new content that reflects the changing living 
and working environments of young adults. We are highly 
enthusiastic about our work and have numerous new 
ideas that we would like to implement. The sword of 
Damocles hanging over the study – our lack of funding – 
means that we will have to consider all of the options for 
financing if we are to continue the cohort study.
In the meantime, and until we solve the problem of 
financing, we will continue to do our utmost to hold on to 
the KiGGS baseline study and KiGGS Wave 1. The cohort 
interview data from KiGGS Wave 2 are simply not ready. 
For the participants who were examined in the study cen-
tres, however, the cohort data set from KiGGS Wave 2 was 
ready earlier, and this means that it was possible to calcu-
late transition probabilities for overweight and obesity, for 
example. For the participants who also submitted a blood 
sample, laboratory parameters could be analysed to study 
developments that had occurred between the two points 
in time. The corresponding ‘laboratory data set’ has got 
again a different sample size. In order to spare Journal 
readers and participants at the KiGGS Symposium any 
confusion, the various data sets – including sample sizes 
– are set out in Table 1.
In addition, the urgent need to be able to plan the future 
of the KiGGS study also influenced our decision to publish 
results from both the cohort and the cross-sectional com-
ponent in a timely manner. We will be able to run KiGGS as 
a cross-sectional study and finance it with the help of the 
Federal Ministry of Health as long as observing the health 
of children and adolescents in Germany continues to be a 
defined task within the framework of Federal Health Mon-
itoring. At the same time, the participants of the KiGGS 
baseline study will probably all be of adult age by the time 
the next wave is conducted; strictly speaking, this will make 
the study’s subtitle ‘German Health Interview and Exami-
nation Survey for Children and Adolescents’ obsolete. It is 
clear that this part of KiGGS can no longer be funded using 
financing from our health monitoring system. However, in 
our view, and from the perspective of public health, this part 
of the study is very important, highly valuable, and unique 
even at the international level. We will also have to change 
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in this issue, and we would be very happy to send you a copy. 
Finally, if you have any further ideas about how KiGGS could 
be continued, we would very much like to hear about them.
our ‘original KiGGS participants’, to contact them and to 
interest and motivate them with our exciting results. We have 
also produced a results booklet from the findings published 
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Overview of the numbers of participants in the 
KiGGS cross-sectional study and the 
KiGGS cohort according to study wave 
Source: KiGGS baseline study (2003-2006), 
KiGGS Wave 1 (2009-2012), 
KiGGS Wave 2 (2014-2017)
KiGGS baseline study 
(cross-sectional and 
longitudinal components)
KiGGS Wave 1 
(cross-sectional 
component)
KiGGS Wave 1 
(longitudinal 
component)
KiGGS Wave 2 
(cross-sectional 
component)
KiGGS Wave 2 
(longitudinal 
component)
Age group (years) 0-17 0-17 6-24 0-17 10-31
Participants in the 
study (total)




17,641 – – 3,567 6,465
Participants with 
blood tests
14,386 – – 3,016 6,044
Cohort participants 
with an interview 
100% – 68.0% – 61.5%
Cohort participants 
with an interview and 
examination
100% – – – 36.6%
This work is licensed under a 
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